Willi Woessmann

1.0k total citations
20 papers, 656 citations indexed

About

Willi Woessmann is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Willi Woessmann has authored 20 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Willi Woessmann's work include Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Immune Cell Function and Interaction (3 papers). Willi Woessmann is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Immune Cell Function and Interaction (3 papers). Willi Woessmann collaborates with scholars based in Germany, United States and Austria. Willi Woessmann's co-authors include Alfred Reiter, Arndt Borkhardt, Christine Damm‐Welk, Xinbin Chen, Wolfram Klapper, Birgit Burkhardt, Ilske Oschlies, Bernhard Kremens, Renate Blütters‐Sawatzki and Peter Lang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Willi Woessmann

19 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Willi Woessmann Germany 14 439 215 156 133 132 20 656
Agnès Chassevent France 10 103 0.2× 211 1.0× 169 1.1× 55 0.4× 58 0.4× 13 785
Susan Eckerle Germany 8 247 0.6× 211 1.0× 184 1.2× 41 0.3× 40 0.3× 12 570
Mi Rim Choi United States 11 255 0.6× 259 1.2× 268 1.7× 21 0.2× 30 0.2× 29 647
Anna Llort Spain 10 103 0.2× 139 0.6× 161 1.0× 99 0.7× 142 1.1× 19 449
Jiaqin Yan China 13 338 0.8× 310 1.4× 118 0.8× 56 0.4× 36 0.3× 39 534
J. P. Lamagnere France 10 146 0.3× 137 0.6× 85 0.5× 39 0.3× 44 0.3× 19 407
ER van Wering Netherlands 12 155 0.4× 123 0.6× 317 2.0× 64 0.5× 47 0.4× 16 1.1k
Beata Holkova United States 13 297 0.7× 307 1.4× 222 1.4× 103 0.8× 32 0.2× 48 634
Anthea Peters Canada 14 245 0.6× 237 1.1× 168 1.1× 66 0.5× 24 0.2× 49 513
Wyndham H. Wilson United States 4 250 0.6× 245 1.1× 340 2.2× 56 0.4× 41 0.3× 7 647

Countries citing papers authored by Willi Woessmann

Since Specialization
Citations

This map shows the geographic impact of Willi Woessmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willi Woessmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willi Woessmann more than expected).

Fields of papers citing papers by Willi Woessmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willi Woessmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willi Woessmann. The network helps show where Willi Woessmann may publish in the future.

Co-authorship network of co-authors of Willi Woessmann

This figure shows the co-authorship network connecting the top 25 collaborators of Willi Woessmann. A scholar is included among the top collaborators of Willi Woessmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willi Woessmann. Willi Woessmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woessmann, Willi, et al.. (2021). Case Report: True Thymic Hyperplasia in a 30-Day-Old Boy. Klinische Pädiatrie. 233(6). 299–302.
2.
Klingebiel, Thomas, Heribert Jürgens, Ingmar Glauche, et al.. (2020). Register und Studien in der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) – Welchen Beitrag leisten sie zum Fortschritt?. Klinische Pädiatrie. 232(3). 124–135. 6 indexed citations
3.
Singh, Vijay K., Holger Hackstein, Volker Lennerz, et al.. (2016). Analysis of nucleophosmin–anaplastic lymphoma kinase (NPM-ALK)-reactive CD8+ T cell responses in children with NPM-ALK+ anaplastic large cell lymphoma. Clinical & Experimental Immunology. 186(1). 96–105. 10 indexed citations
4.
Woessmann, Willi. (2015). Prognostic factors in paediatric anaplastic large cell lymphoma role of ALK. Frontiers in Bioscience-Scholar. 7(2). 205–216. 14 indexed citations
5.
Kontny, Udo, Ilske Oschlies, Willi Woessmann, et al.. (2014). Non‐anaplastic peripheral T‐cell lymphoma in children and adolescents – a retrospective analysis of the NHL‐BFM study group. British Journal of Haematology. 168(6). 835–844. 29 indexed citations
6.
Körholz, Dieter, et al.. (2014). Grey Zone Lymphoma in Children and Adolescents: Experience of Pediatric Hodgkin and Non-Hodgkin Study Groups. Klinische Pädiatrie. 226(2). 1 indexed citations
7.
Woessmann, Willi, L. Brugiéres, A Rosolen, et al.. (2012). Risk-adapted therapy for patients with relapsed or refractory ALCL - interim-results of the prospective EICNHL-Trial ALCL-relapse. British Journal of Haematology. 159. 41–41. 4 indexed citations
8.
Cairo, Mitchell S., Willi Woessmann, & John M. Pagel. (2012). Advances in Hematopoietic Stem Cell Transplantation in Childhood and Adolescent Lymphomas. Biology of Blood and Marrow Transplantation. 19(1). S38–S43. 6 indexed citations
9.
Cerchietti, Leandro, Christine Damm‐Welk, Inga Vater, et al.. (2011). Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas. PLoS ONE. 6(4). e18436–e18436. 39 indexed citations
10.
Woessmann, Willi, Martin Zimmermann, M. James Lenhard, et al.. (2011). Relapsed or Refractory Anaplastic Large-Cell Lymphoma in Children and Adolescents After Berlin-Frankfurt-Muenster (BFM)–Type First-Line Therapy: A BFM-Group Study. Journal of Clinical Oncology. 29(22). 3065–3071. 70 indexed citations
11.
Hackstein, Holger, et al.. (2009). Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Transfusion. 49(11). 2366–2373. 28 indexed citations
12.
Damm‐Welk, Christine, Wolfram Klapper, Ilske Oschlies, et al.. (2009). Distribution of NPM1‐ALK and X‐ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular–histological correlation. British Journal of Haematology. 146(3). 306–309. 46 indexed citations
13.
14.
15.
Woessmann, Willi, Christina Peters, M. James Lenhard, et al.. (2006). Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents – a Berlin–Frankfurt–Münster group report. British Journal of Haematology. 133(2). 176–182. 84 indexed citations
16.
Woessmann, Willi, et al.. (2004). ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent. Cell Biology International. 28(5). 403–410. 29 indexed citations
17.
Damm‐Welk, Christine, et al.. (2003). Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL). Oligonucleotides. 13(5). 365–373. 29 indexed citations
18.
Woessmann, Willi, Christine Damm‐Welk, Uta Fuchs, & Arndt Borkhardt. (2003). RNA interference: new mechanisms for targeted treatment?. PubMed. 7(3). 270–91. 15 indexed citations
19.
Woessmann, Willi, et al.. (2003). Successful chemotherapy for melanotic neuroectodermal tumor of infancy in a baby. Medical and Pediatric Oncology. 40(3). 198–199. 58 indexed citations
20.
Woessmann, Willi, Xinbin Chen, & Arndt Borkhardt. (2002). Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. Cancer Chemotherapy and Pharmacology. 50(5). 397–404. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnès Chassevent Breakdown of academic impact, for papers by Susan Eckerle Breakdown of academic impact, for papers by Mi Rim Choi Breakdown of academic impact, for papers by Anna Llort Breakdown of academic impact, for papers by Jiaqin Yan Breakdown of academic impact, for papers by J. P. Lamagnere Breakdown of academic impact, for papers by ER van Wering Breakdown of academic impact, for papers by Beata Holkova Breakdown of academic impact, for papers by Anthea Peters Breakdown of academic impact, for papers by Wyndham H. Wilson
Rankless by CCL
2026